Literature DB >> 6157565

Selective inhibition of Ectromelia virus DNA synthesis in hepatocytes by adenine-9-beta-D-arabinofuranoside (ara-A) and adenine-9-beta-D-arabinofuranoside 5'-monophosphate (ara-AMP) conjugated to asialofetuin.

L Fiume, A Mattioli, C Busi, P G Balboni, G Barbanti-Brodano, J De Vries, R Altmann, T Wieland.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6157565     DOI： 10.1016/0014-5793(80)80639-9

Source DB:  PubMed          Journal:  FEBS Lett        ISSN： 0014-5793            Impact factor:   4.124


× No keyword cloud information.
  8 in total

Review 1.  GalNAc-siRNA Conjugates: Leading the Way for Delivery of RNAi Therapeutics.

Authors:  Aaron D Springer; Steven F Dowdy
Journal:  Nucleic Acid Ther       Date:  2018-05-24       Impact factor: 5.486

Review 2.  Targeting hepatitis B therapy to the liver. Clinical pharmacokinetic considerations.

Authors:  P C Rensen; R L de Vrueh; T J van Berkel
Journal:  Clin Pharmacokinet       Date:  1996-08       Impact factor: 6.447

3.  Synthesis and pharmacokinetics of a new liver-specific carrier, glycosylated carboxymethyl-dextran, and its application to drug targeting.

Authors:  M Nishikawa; A Kamijo; T Fujita; Y Takakura; H Sezaki; M Hashida
Journal:  Pharm Res       Date:  1993-09       Impact factor: 4.200

4.  A study on the pharmacokinetics in mouse of adenine-9-beta-D-arabinofuranoside 5-monophosphate conjugated with lactosaminated albumin.

Authors:  L Fiume; B Bassi; C Busi; A Mattioli; T Wieland
Journal:  Experientia       Date:  1985-10-15

5.  Conjugates of adenine 9-alpha-D-arabinofuranoside monophosphate (ara-AMP) with lactosaminated homologous albumin are not immunogenic in the mouse.

Authors:  L Fiume; A Mattioli; C Busi; G Spinosa; T Wieland
Journal:  Experientia       Date:  1982-09-15

6.  Selective penetration and pharmacological activity of lactosaminated albumin conjugates of adenine arabinoside 5-monophosphate (ara-AMP) in mouse liver.

Authors:  L Fiume; A Mattioli; C Busi; C Accorsi
Journal:  Gut       Date:  1984-12       Impact factor: 23.059

7.  [Approaches to a selective chemotherapy of hepatocellular carcinoma (author's transl)].

Authors:  J Pausch; A Holstege; D Keppler; W Gerok
Journal:  Klin Wochenschr       Date:  1981-06-15

8.  Ligand conjugate SAR and enhanced delivery in NHP.

Authors:  Richard James Holland; Kieu Lam; Xin Ye; Alan D Martin; Mark C Wood; Lorne Palmer; David Fraser; Kevin McClintock; Sara Majeski; Agnes Jarosz; Amy C H Lee; Emily P Thi; Adam Judge; James Heyes
Journal:  Mol Ther       Date:  2021-06-04       Impact factor: 12.910
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.